Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Lou, E; Turner, S; Sumrall, A; Reardon, DA; Desjardins, A; Peters, KB; Sampson, JH; Friedman, HS; Vredenburgh, JJ

Published Date

  • October 1, 2011

Published In

Volume / Issue

  • 29 / 28

Start / End Page

  • e739 - e742

PubMed ID

  • 21900098

Pubmed Central ID

  • 21900098

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.36.1865

Language

  • eng

Conference Location

  • United States